fenoldopam has been researched along with Glomerulonephritis, Membranous in 1 studies
Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.
Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sampaio-Maia, B | 1 |
| Moreira-Rodrigues, M | 1 |
| Serrão, P | 1 |
| Pestana, M | 1 |
1 other study available for fenoldopam and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Blunted renal dopaminergic system activity in HgCl2-induced membranous nephropathy.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Dopamine; Dopamine Agonists; Fenoldopam; Glomerulonep | 2006 |